C-Reactive Protein As A Response Indicator In Drug-Naïve Patients With Major Depressive Disorder: A Hospital-Based Study
Abstract Objective: C-reactive protein (CRP) is an indicator of the inflammatory process in the body, and is associated with the pathogenesis of depression through its purported effect on neurotransmitter function in the brain. Current research aims to study the relationship between the levels of...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Rawalpindi Medical University
2023-12-01
|
| Series: | Journal of Rawalpindi Medical College |
| Subjects: | |
| Online Access: | https://www.journalrmc.com/index.php/JRMC/article/view/2343 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832086968059559936 |
|---|---|
| author | Ather Muneer Nargis Munir Nadia Shams Mirza Inam Usman Ghani Neelam Ayub |
| author_facet | Ather Muneer Nargis Munir Nadia Shams Mirza Inam Usman Ghani Neelam Ayub |
| author_sort | Ather Muneer |
| collection | DOAJ |
| description |
Abstract
Objective: C-reactive protein (CRP) is an indicator of the inflammatory process in the body, and is associated with the pathogenesis of depression through its purported effect on neurotransmitter function in the brain. Current research aims to study the relationship between the levels of CRP and the rate of remission of major depressive disorder with first-line antidepressant therapy.
Methods: This hospital-based prospective study included thirty patients by purposive sampling technique. Patients with first-episode MDD with no history of antidepressant exposure and other medical comorbidity were recruited for pharmacotherapy with escitalopram, a first-line antidepressant. Patients taking antidepressants, anti-inflammatory medicines, having co-morbid conditions or other psychiatric conditions were excluded. The baseline CRP levels were measured and depressive symptoms were evaluated using the Hamilton Rating Scale for Depression (HRSD) at weeks 0, 6 and 12. The patients with low (≤5 mg/l) and high (>5 mg/l) CRP levels were compared for remission rates at week 12 using Kaplan–Meier survival analysis.
Results: Amongst the 30 cases, 11(36.7%) were males and 19(63.3%) were female patients. The mean age was 35.95±7.85 years. Both groups were matched concerning age, gender, BMI and baseline HRSD score (p>0.05). As per Kaplan–Meier survival analysis, a significantly higher proportion of patients had remission of MDD at the 12th week having CRP levels ≤5 mg/l than the patients with CRP levels >5 mg/dl (p=0.002).
Conclusion: This research concluded that after an adequate trial with a standard antidepressant, higher levels of CRP could lead to poorer remission rates in MDD subjects and could represent a sub-group of patients with treatment resistance.
|
| format | Article |
| id | doaj-art-a4d8eab5e100469fbe2180b2b5a61185 |
| institution | Kabale University |
| issn | 1683-3562 1683-3570 |
| language | English |
| publishDate | 2023-12-01 |
| publisher | Rawalpindi Medical University |
| record_format | Article |
| series | Journal of Rawalpindi Medical College |
| spelling | doaj-art-a4d8eab5e100469fbe2180b2b5a611852025-02-06T08:40:34ZengRawalpindi Medical UniversityJournal of Rawalpindi Medical College1683-35621683-35702023-12-0127410.37939/jrmc.v27i4.2343C-Reactive Protein As A Response Indicator In Drug-Naïve Patients With Major Depressive Disorder: A Hospital-Based Study Ather Muneer0Nargis Munir1Nadia ShamsMirza Inam2Usman Ghani3Neelam Ayub4HBS IslamabadRIHS IslamabadRIHS IslamabadRai Medical College RIHS Islamabad Abstract Objective: C-reactive protein (CRP) is an indicator of the inflammatory process in the body, and is associated with the pathogenesis of depression through its purported effect on neurotransmitter function in the brain. Current research aims to study the relationship between the levels of CRP and the rate of remission of major depressive disorder with first-line antidepressant therapy. Methods: This hospital-based prospective study included thirty patients by purposive sampling technique. Patients with first-episode MDD with no history of antidepressant exposure and other medical comorbidity were recruited for pharmacotherapy with escitalopram, a first-line antidepressant. Patients taking antidepressants, anti-inflammatory medicines, having co-morbid conditions or other psychiatric conditions were excluded. The baseline CRP levels were measured and depressive symptoms were evaluated using the Hamilton Rating Scale for Depression (HRSD) at weeks 0, 6 and 12. The patients with low (≤5 mg/l) and high (>5 mg/l) CRP levels were compared for remission rates at week 12 using Kaplan–Meier survival analysis. Results: Amongst the 30 cases, 11(36.7%) were males and 19(63.3%) were female patients. The mean age was 35.95±7.85 years. Both groups were matched concerning age, gender, BMI and baseline HRSD score (p>0.05). As per Kaplan–Meier survival analysis, a significantly higher proportion of patients had remission of MDD at the 12th week having CRP levels ≤5 mg/l than the patients with CRP levels >5 mg/dl (p=0.002). Conclusion: This research concluded that after an adequate trial with a standard antidepressant, higher levels of CRP could lead to poorer remission rates in MDD subjects and could represent a sub-group of patients with treatment resistance. https://www.journalrmc.com/index.php/JRMC/article/view/2343C-Reactive ProteinEscitalopramMajor Depressive DisorderRemissionTreatment-resistance |
| spellingShingle | Ather Muneer Nargis Munir Nadia Shams Mirza Inam Usman Ghani Neelam Ayub C-Reactive Protein As A Response Indicator In Drug-Naïve Patients With Major Depressive Disorder: A Hospital-Based Study Journal of Rawalpindi Medical College C-Reactive Protein Escitalopram Major Depressive Disorder Remission Treatment-resistance |
| title | C-Reactive Protein As A Response Indicator In Drug-Naïve Patients With Major Depressive Disorder: A Hospital-Based Study |
| title_full | C-Reactive Protein As A Response Indicator In Drug-Naïve Patients With Major Depressive Disorder: A Hospital-Based Study |
| title_fullStr | C-Reactive Protein As A Response Indicator In Drug-Naïve Patients With Major Depressive Disorder: A Hospital-Based Study |
| title_full_unstemmed | C-Reactive Protein As A Response Indicator In Drug-Naïve Patients With Major Depressive Disorder: A Hospital-Based Study |
| title_short | C-Reactive Protein As A Response Indicator In Drug-Naïve Patients With Major Depressive Disorder: A Hospital-Based Study |
| title_sort | c reactive protein as a response indicator in drug naive patients with major depressive disorder a hospital based study |
| topic | C-Reactive Protein Escitalopram Major Depressive Disorder Remission Treatment-resistance |
| url | https://www.journalrmc.com/index.php/JRMC/article/view/2343 |
| work_keys_str_mv | AT athermuneer creactiveproteinasaresponseindicatorindrugnaivepatientswithmajordepressivedisorderahospitalbasedstudy AT nargismunir creactiveproteinasaresponseindicatorindrugnaivepatientswithmajordepressivedisorderahospitalbasedstudy AT nadiashams creactiveproteinasaresponseindicatorindrugnaivepatientswithmajordepressivedisorderahospitalbasedstudy AT mirzainam creactiveproteinasaresponseindicatorindrugnaivepatientswithmajordepressivedisorderahospitalbasedstudy AT usmanghani creactiveproteinasaresponseindicatorindrugnaivepatientswithmajordepressivedisorderahospitalbasedstudy AT neelamayub creactiveproteinasaresponseindicatorindrugnaivepatientswithmajordepressivedisorderahospitalbasedstudy |